Raquel E. Izumi - 09 Aug 2023 Form 4 Insider Report for Vincerx Pharma, Inc. (VINC)

Role
President and Chief Operations Officer, Director
Signature
By: /s/ Raquel E. Izumi
Issuer symbol
VINC
Transactions as of
09 Aug 2023
Net transactions value
+$14,934
Form type
4
Filing time
10 Aug 2023, 18:27:53 UTC
Previous filing
16 Feb 2023
Next filing
08 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VINC Common Stock Purchase $11,735 +13,036 +19% $0.9002 81,774 09 Aug 2023 Izumi-Covey 2000 Revocable Trust U/A 01/09/01 F1
transaction VINC Common Stock Purchase $3,199 +3,440 +4.2% $0.9300 85,214 10 Aug 2023 Izumi- Covey 2000 Revocable Trust U/A 01/09/01 F2
holding VINC Common Stock 1,000 09 Aug 2023 By spouse's Rollover IRA
holding VINC Common Stock 1,618,199 09 Aug 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a weighted average purchase price. Actual purchase prices ranged from $0.90 to $0.94 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares purchased within the range indicated.
F2 Represents actual price

Remarks:

President and Chief Operations Officer